文献速递肝病

自噬基因MTMR12和FAM134A变异是α1-抗胰蛋白酶缺乏症肝脏表型的推定修饰因子

Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in α1-antitrypsin deficiency.
PubMed 文献 · Hepatology · 2024-04-01

研究对一个肝衰竭先证者及两名无肝病纯合同胞进行基因组测序,并与有/无肝病纯合子队列比较,在iPS来源肝细胞样细胞中检测候选变异对α1-抗胰蛋白酶Z降解的影响。结果显示MTMR12和FAM134A变异可各自加速先证者细胞中Z的降解,但需同时携带两变异才能减缓受保护同胞细胞中Z的降解。

要点

  • MTMR12和FAM134A变异可分别加速先证者细胞中α1-抗胰蛋白酶Z降解。
  • 需同时遗传MTMR12和FAM134A两变异才能在细胞水平介导肝脏蛋白毒性效应。
  • 纯合子队列分析提示多个患者特异性蛋白稳态基因变异可解释人群肝病易感性。

核心结论

  • 自噬功能的遗传变异可决定α1-抗胰蛋白酶缺乏症肝病易感性,蛋白毒性病理可能需要多基因机制和多个患者特异性变异。

研究设计与样本

  • 对一个肝衰竭先证者及两名无或轻微肝病的纯合同胞进行基因组测序。
  • 将序列与有或无肝病的特征明确的纯合子队列比较。
  • 在来自受累同胞的iPS来源肝细胞样细胞中检测候选序列变异对α1-抗胰蛋白酶Z降解动力学的影响。

主要发现

  • MTMR12和FAM134A变异可各自加速先证者细胞中α1-抗胰蛋白酶Z的降解。
  • 需同时携带MTMR12和FAM134A两变异才能减缓受保护同胞细胞中α1-抗胰蛋白酶Z的降解。
  • 纯合子队列分析显示多个患者特异性蛋白稳态基因变异可能解释人群水平的肝病易感性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In the classical form of α1-antitrypsin deficiency, a misfolded variant α1-antitrypsin Z accumulates in the endoplasmic reticulum of liver cells and causes liver cell injury by gain-of-function proteotoxicity in a sub-group of affected homozygotes but relatively little is known about putative modifiers. Here, we carried out genomic sequencing in a uniquely affected family with an index case of liver failure and 2 homozygous siblings with minimal or no liver disease. Their sequences were compared to sequences in well-characterized cohorts of homozygotes with or without liver disease, and then candidate sequence variants were tested for changes in the kinetics of α1-antitrypsin variant Z degradation in iPS-derived hepatocyte-like cells derived from the affected siblings themselves. APPROACH AND RESULTS: Specific variants in autophagy genes MTMR12 and FAM134A could each accelerate the degradation of α1-antitrypsin variant Z in cells from the index patient, but both MTMR12 and FAM134A variants were needed to slow the degradation of α1-antitrypsin variant Z in cells from a protected sib, indicating that inheritance of both variants is needed to mediate the pathogenic effects of hepatic proteotoxicity at the cellular level. Analysis of homozygote cohorts showed that multiple patient-specific variants in proteostasis genes are likely to explain liver disease susceptibility at the population level. CONCLUSIONS: These results validate the concept that genetic variation in autophagy function can determine susceptibility to liver disease in α1-antitrypsin deficiency and provide evidence that polygenic mechanisms and multiple patient-specific variants are likely needed for proteotoxic pathology.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Tafaleng EN, Li J, Wang Y, et al. Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in α1-antitrypsin deficiency. Hepatology. 2024. PMID: 38557779. doi:10.1097/HEP.0000000000000865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。